FASEB SRC: The Translational Neuroimmunology Conference: From Bench to Bedside and Back
FASEB SRC:转化神经免疫学会议:从实验室到临床并返回
基本信息
- 批准号:10539690
- 负责人:
- 金额:$ 3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-15 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AgingAnimal ModelAreaAstrocytesBackBiological AgingBiological ProductsBiomedical ResearchCD8-Positive T-LymphocytesClinicalCollaborationsCommunicationCommunitiesComplexCritical PathwaysDevelopmentDisciplineDiseaseEducational workshopEnsureEpilepsyEquipoiseEvaluation ResearchFDA approvedFacultyFosteringFutureGeneticGoalsHealthHomeostasisHumanImmuneImmune systemIndividualInflammatoryInvestigationKnowledgeMedicineMentorsMicrogliaModelingMultiple SclerosisMyasthenia GravisNervous system structureNeurodegenerative DisordersNeuroimmuneNeurologicNeuromyelitis OpticaNorth CarolinaPathologyPathway interactionsPostdoctoral FellowRenaissanceResearchResearch PersonnelRoleSTEM fieldScienceScientistSeriesTimeTranslatingTranslationsUnderrepresented MinorityUnderrepresented PopulationsWomanbench to bedsidecareerdesignextracellular vesiclesgraduate studenthuman diseaseimagerinsightinterestmeetingsmicrobiomenervous system disorderneurodevelopmentneuroimmunologyneuroinflammationneurotoxicnew technologynext generationoral communicationpeerpostersprogramsrecruitresponserole modelsensorsuccesssupportive environmentsymposium
项目摘要
Project Summary
The purpose of this R13 proposal is to support the attendance of trainees, young investigators, and individuals
historically underrepresented in science and medicine, at the 2022 FASEB Conference: Translational
Neuroimmunology: From Bench to Bedside and Back. This will be the 15th biannual FASEB Neuroimmunology
conference, the first having been held in 1988. The current meeting will be held August 29-September 2, 2022
at the Renaissance Asheville Hotel in Asheville, North Carolina. Neuroimmunology is one of the fastest
growing fields in biomedical research. It has also been one of the most fruitful in terms of the successful
translation of wet bench discoveries into impactful clinical therapies. The overall intent of this conference is to
bring together the world’s leading scientists, young investigators, and trainees, who are engaged in
neuroimmunology research from a broad range of perspectives, in a collegial and supportive environment. The
specific goals are to: 1) provide a forum for the presentation of unpublished, cutting-edge research on immune-
nervous system interactions during health and disease, by speakers from diverse backgrounds; 2) provide
opportunities for both formal and informal discussions on neuroimmune pathways in health and disease, the
environmental and genetic factors that influence those pathways, and efforts to translate scientific insights in
neuroimmunology from “bench to bedside”; 3) support the participation of young investigators, particularly
those traditionally under-represented in the field, and facilitate their integration into the broader research
community in a meaningful and interactive way; (4) promote principles of rigor, transparency, and equipoise in
the conduct and evaluation of research. The program is intentionally multifaceted to ensure that attendees
working on different aspects of Neuroimmunology research have the opportunity to meet colleagues with
complementary interests and areas of expertise, either one-on-one or in small group settings. The agenda
consists of a series of sequential sessions in a single track, without competing talks, and unscheduled
afternoon time to encourage informal communications. These collective features of the conference will facilitate
brainstorming and mentoring in a variety of formats. A priority is to inspire women scientists, and learners and
junior faculty from groups that are traditionally underrepresented in science and medicine, and to connect
those individuals with role models, future mentors, and peers, thereby strengthening their commitment to
Neuroimmunology research. To that end, we are introducing workshops on “How to Forge Collaborations with
Clinicians and Translate Wet Bench Findings to Human Studies”; “Women and Under-represented Minorities in
Neuroimmunology: Challenges and Opportunities”; and “Scientific Rigor and Transparency in Research”, as
well as a career panel discussion on “Career Trajectories in Neuroimmunology”. This conference is designed
to foster creative partnerships and collaborations between wet bench scientists, clinical trialists/ researchers,
and clinicians who are focused on Neuroimmunology, ultimately leading to clinical advances in the field.
项目摘要
本R13提案的目的是支持受训人员、年轻调查人员和个人的出席
在2022年FASEB会议上,在科学和医学领域历史上代表性不足:翻译
神经免疫学:从长凳到床边和背部。这将是第15届FASE B神经免疫学双年展
第一次会议于1988年举行。本次会议将于2022年8月29日至9月2日举行。
在北卡罗来纳州阿什维尔的文艺复兴阿什维尔酒店。神经免疫学是最快的
不断增长的生物医学研究领域。它也是最富有成效的成功案例之一
将湿工作台的发现转化为有效的临床疗法。这次会议的总体意图是
汇聚世界顶尖的科学家、青年研究人员和实习生,他们从事
在大学和支持性环境中,从广泛的角度进行神经免疫学研究。这个
具体目标是:1)提供一个论坛,展示未发表的关于免疫的前沿研究-
来自不同背景的演讲者在健康和疾病期间的神经系统互动;2)提供
就健康和疾病中的神经免疫途径进行正式和非正式讨论的机会,
影响这些途径的环境和遗传因素,以及将科学见解转化为
神经免疫学从“工作台到床边”;3)支持年轻研究人员的参与,特别是
那些传统上在实地代表性不足的人,并促进他们融入更广泛的研究
以有意义和互动的方式建立社区;(4)促进严格、透明和均衡的原则
研究的进行和评估。该计划是有意多方面的,以确保与会者
从事神经免疫学研究的不同方面的工作有机会与
相互补充的兴趣和专长领域,无论是一对一的还是在小组环境中。议事日程
由单一轨道中的一系列连续会话组成,没有竞争的演讲,并且未计划
下午是鼓励非正式交流的时间。会议的这些集体特点将促进
各种形式的集思广益和辅导。当务之急是激励女性科学家、学习者和
来自传统上在科学和医学领域代表性不足的团体的初级教员,并将
这些人有榜样、未来的导师和同龄人,从而加强他们对
神经免疫学研究。为此,我们正在举办关于“如何与
临床医生和将湿工作台研究结果转化为人类研究“;”妇女和代表不足的少数群体“
神经免疫学:挑战和机遇“;以及”研究中的科学严谨性和透明度“,AS
以及职业小组讨论“神经免疫学中的职业轨迹”。这次会议是专门设计的
为了促进湿凳科学家、临床试验者/研究人员之间的创造性伙伴关系和合作,
以及专注于神经免疫学的临床医生,最终导致该领域的临床进步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Benjamin M Segal其他文献
Benjamin M Segal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Benjamin M Segal', 18)}}的其他基金
Arginase-1 and iNOS expressing CNS myeloid cell subsets in EAE and MS
EAE 和 MS 中表达精氨酸酶 1 和 iNOS 的 CNS 骨髓细胞亚群
- 批准号:
10221066 - 财政年份:2019
- 资助金额:
$ 3万 - 项目类别:
A novel inflammatory cell with neuroprotective and neuroregenerative properties
一种具有神经保护和神经再生特性的新型炎症细胞
- 批准号:
10391439 - 财政年份:2018
- 资助金额:
$ 3万 - 项目类别:
A novel inflammatory cell with neuroprotective and neuroregenerative properties
一种具有神经保护和神经再生特性的新型炎症细胞
- 批准号:
9900003 - 财政年份:2018
- 资助金额:
$ 3万 - 项目类别:
The mechanism of action of Granulocyte Macrophage-Colony Stimulating Factor in an animal model of Multiple Sclerosis
粒细胞巨噬细胞集落刺激因子在多发性硬化症动物模型中的作用机制
- 批准号:
9392704 - 财政年份:2017
- 资助金额:
$ 3万 - 项目类别:
Immune mediated regeneration of retinal ganglion cell axons following optic nerve trauma
视神经损伤后免疫介导的视网膜神经节细胞轴突再生
- 批准号:
10017241 - 财政年份:2017
- 资助金额:
$ 3万 - 项目类别:
Immune mediated regeneration of retinal ganglion cell axons following optic nerve trauma
视神经损伤后免疫介导的视网膜神经节细胞轴突再生
- 批准号:
9390608 - 财政年份:2017
- 资助金额:
$ 3万 - 项目类别:
Nogo Receptors as Therapeutic Targets in a Model of Multiple Sclerosis
Nogo 受体作为多发性硬化症模型的治疗靶点
- 批准号:
8774166 - 财政年份:2013
- 资助金额:
$ 3万 - 项目类别:
Nogo Receptors as Therapeutic Targets in a Model of Multiple Sclerosis
Nogo 受体作为多发性硬化症模型的治疗靶点
- 批准号:
8441391 - 财政年份:2013
- 资助金额:
$ 3万 - 项目类别:
Nogo Receptors as Therapeutic Targets in a Model of Multiple Sclerosis
Nogo 受体作为多发性硬化症模型的治疗靶点
- 批准号:
8625179 - 财政年份:2013
- 资助金额:
$ 3万 - 项目类别:
Preclinical studies of a MADCAM-Fc fusion protein in multiple sclerosis
MADCAM-Fc 融合蛋白治疗多发性硬化症的临床前研究
- 批准号:
8931020 - 财政年份:2011
- 资助金额:
$ 3万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 3万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 3万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 3万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 3万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 3万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 3万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 3万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists